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The multifunctional HIV-1 protein Nef possesses several motifs that interact with signaling molecules in infected T cells. In order to
determine whether Nef influences T cell activation, cells were infected with Nef-positive and Nef-negative clones of HIV. CD28 expression
and changes in tyrosine phosphorylation were monitored. We observed no Nef-dependent changes in CD28 expression or function. However,
infection with Nef-positive virus led to changes in tyrosine phosphorylation. This Nef-induced phosphorylation was observed in unstimulated
cells, and c-Cbl was identified as one of the proteins whose phosphorylation was upregulated by Nef. Furthermore, Lck is required for Nef-
mediated c-Cbl tyrosine phosphorylation. These results suggest that Nef modifies T cell signaling in the absence of T cell receptor
engagement and co-stimulation.
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HIV-1 Nef is a 27- to 34-kDa myristoylated protein that
has been demonstrated to be critical for viral pathogenesis in
part by promoting aberrant T cell function (Fackler and Baur,
2002; Renkema and Saksela, 2000). Nef is expressed
throughout the HIV replication cycle and packaged in mature
virions (Kotov et al., 1999; Pandori et al., 1996; Wu and
Marsh, 2001). In infected CD4+ T lymphocytes, expression
of Nef downregulates CD4 and MHC class I molecules by0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: ajh6@psu.edu (A.J. Henderson).targeting endocytosis and post-translation sorting, respec-
tively (Aiken et al., 1994; Blagoveshchenskaya et al., 2002;
Chen et al., 1996; Garcia and Miller, 1991; Greenberg et al.,
1998; Schwartz et al., 1996). Reduced MHC I expression
allows evasion of CTL surveillance, while decreased CD4
levels enhance virion release by reducing gp120–CD4
interactions during budding (Cohen et al., 1999; Collins et
al., 1998). Nef has also been shown to influence apoptosis,
protecting infected CD4+ T cells against apoptosis while
elevating CD95L expression to induce apoptosis of
bystander cells (Geleziunas et al., 2001; Greenway et al.,
2002; Wolf et al., 2001; Xu et al., 1999).
Several structural motifs and functional properties of Nef
suggest it has a role in modulating signal transduction (Ren-
kema and Saksela, 2000). Myristoylation at the N terminus
anchors Nef to the inner leaflet of the plasma membrane,
where it associates with lipid rafts and physically interacts
with CD3-~ of the TCR complex (Wang et al., 2000; Xu et
al., 1999). The ability of Nef to modify TCR signaling is
suggested by recent studies in which overexpression of Nef
induced a transcriptional response in CD4+ T cells that was
similar to CD3 signaling (Simmons et al., 2001). Moreover,
Nef possesses a proline-rich motif, which mediates interac-05) 219 – 228
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nucleotide-exchange factor Vav, and the Src family kinase Lck
(Baur et al., 1997; Collette et al., 1996; Fackler et al., 1999;
Saksela et al., 1995). The Nef–Vav complex recruits p21-
activated kinases (PAK1/2) through the Arg–Arg (RR) motif of
Nef and small G proteins Rac/cdc42 (Renkema et al., 2001),
inducing cellular responses ranging from cytoskeletal reorgan-
ization to respiratory burst (Fackler et al., 1999, 2000; Vilhardt
et al., 2002). Taken together, Nef targets multiple biochemical
events that directly impact HIV replication and the survival and
function of infected host cells.
Cbl family proteins regulate antigen-dependent activation
of thymocytes and circulating T lymphocytes (Lupher et al.,
1999; Thien and Langdon, 2001). The proto-oncogene cbl
encodes a 906-amino acid, multi-domain protein, c-Cbl,
whose primary function is to regulate tyrosine kinases
(Donovan et al., 1994; Loreto et al., 2002; Ota and
Samelson, 1997). In addition to c-Cbl, there are two
mammalian homologues: Cbl-b, which is 982 amino acids
and mainly expressed in peripheral T lymphocytes, and the
truncated Cbl-3, which is 474 amino acids (Keane et al.,
1995; Thien and Langdon, 2001). The three proteins share
tyrosine kinase-binding (TKB), linker, and RING finger
domains. The TKB domain consists of a four-helix bundle
(4H), a Ca2+-binding EF hand (EF), and Src homology
region 2 (SH2) that is connected to a RING finger by the
linker domain (Thien and Langdon, 2001). The SH2 domain
has been demonstrated to bind to receptor tyrosine kinases,
including CSF-1 receptor, EGFR, and PDGFR (Lee et al.,
1999; Levkowitz et al., 1998; Miyake et al., 1999), as well as
non-receptor tyrosine kinases such as Syk and ZAP-70,
which associates with CD3-~ of the TCR complex (Fournel
et al., 1996; Lupher et al., 1996; Ota and Samelson, 1997;
Rao et al., 2001). The RING finger E3 ubiquitin ligase
domain recruits ubiquitin-conjugating enzymes (E2s) that
catalyzes multiple ubiquitination of Cbl-interacting proteins,
targeting them for proteosome degradation and thus neg-
atively regulating T cell signaling (Levkowitz et al., 1999;
Naramura et al., 2002; Panigada et al., 2002). C-Cbl and Cbl-
b also interact with SH3-possessing Src family kinases Lck
and Fyn, as well as adaptor proteins Nck and Grb2 through
C-terminal proline-rich motifs (Andoniou et al., 2000;
Donovan et al., 1996; Feshchenko et al., 1998; Ojaniemi et
al., 1997). Src kinase-dependent tyrosine phosphorylation of
Cbl proteins facilitates the recruitment of additional factors
such as Vav and PI3K, which are required for T cell
activation (Lupher et al., 1999; Marengere et al., 1997;
Miura-Shimura et al., 2003). As HIV-1 Nef has also been
shown to physically and functionally interact with Vav and
PI3K, it is possible that direct or indirect interactions
between Nef and Cbl proteins impact T cell activation and
influence HIV replication.
In order to understand the effects of Nef on CD4+ T
cell signaling, we examined tyrosine phosphorylation
patterns in HIV infected Jurkat T cells. We report that
Nef enhances tyrosine phosphorylation of c-Cbl. Thisupregulation of c-Cbl tyrosine phosphorylation is induced
by endogenous expression of Nef in HIV-1-infected cells
and requires the Src tyrosine kinase Lck.Results
HXB2 Nef does not adversely affect CD28 expression and
function
Nef interacts with integral components of the TCR/
CD28 signaling network in CD4+ T cells, including Fyn,
Lck, Vav, and PI3K. It has been previously reported that
Nef down-regulates surface expression of CD28, thus
altering CD28 signaling and T cell activation (Swigut et
al., 2001). Since we were interested in determining if T cell
signaling pathways, including those emanating from CD28,
are targeted by Nef in the context of viral infection, we
assessed CD28 surface expression and function in the
absence and presence of HIV infection. CD4+ Jurkat T cells
were infected with HXBnPLAP-IRES-N+ (HIV-Nef+)
(Chen et al., 1996) and examined for changes in CD28
expression. This molecular clone has a PLAP-encoding
cDNA inserted in the restored HXB2 nef open reading
frame (ORF). HXB2 Nef expression is driven by an
internal ribosomal entry site from the encephalomyocarditis
virus (EMCV) inserted 3V to the PLAP ORF (Chen et al.,
1996). PLAP, a surface protein not found in T cells, serves
as a positive marker for HIV infection as determined by
flow cytometry (Fig. 1A).
To confirm that physiological levels of Nef were being
expressed in HXBnPLAP virus-infected cells, we compared
Nef expression in HIV-Nef+-infected cells with Jurkat T cells
infected with NL4-3 and PMA-stimulated ACH-2 T cells,
which harbor inducible provirus (Clouse et al., 1989). As
shown in Fig. 1B, comparable levels of Nef protein were
observed in the HIV-Nef+ and NL4-3 HIV-infected cells as
well as the activated ACH-2 cell line, suggesting that the
levels of Nef protein expressed by the HXBnPLAP clone are
representative of those found in cells actively replicating
HIV.
The ability of Nef to down-regulate surface CD28 and
alter its functions was examined. We used flow cytometry to
monitor PLAP and CD28 expression on the surface of HIV-
infected cells. HIV-infected (PLAP+) cells expressed CD28
at levels that were comparable to mock-infected Jurkat Tcells
or uninfected Jurkat T cells exposed to virus (PLAP cells)
(Fig. 1C). To determine if CD28 signaling was affected by
Nef, we co-transfected Jurkat T cells with HXB2 Nef and
HIV-LTR luciferase reporter to determine if Nef influenced
CD28 signaling. As reported previously, CD28-dependent
induction of HIV transcription required cross-linking of CD3
and CD28, whereas cross-linking CD28 was not sufficient to
induce LTR activity and CD3 alone resulted in only a modest
induction of LTR activity (Fig. 1C; Cook et al., 2003). The
synergistic activation of the HIV LTR by co-stimulation with
Fig. 1. Nef does not downregulate CD28 expression or function. (A) Jurkat T cells were mock-infected or infected with HXBnPLAP-IRES-N+. Populations of
infected or mock-infected cells were stained for PLAP and CD28 and analyzed by flow cytometry. Numbers indicate MFIs of CD28 expression of populations
in respective quadrants. (B) Expression of Nef in Jurkat T cells infected with HXBnPLAP-IRES-N+. Whole-cell extracts were prepared from HIV-Nef+ and
NL4-3-infected cells 4 days post-infection, as well as ACH-2 cells treated with 10 ng/ml of PMA for 24 h. Nef was detected by immunoblotting with anti-Nef
anti-serum. The Nef from HXBnPLAP-IRES-N+ migrates slightly slower than Nef from NL4-3 HIVand induced provirus of ACH-2. Blots were reprobed with
anti-Gag antibody to show relative virus expression. (C) CD28 expressions in infected and uninfected cells were compared. For the CD28 expression profile, in
ascending order, the histograms are: isotype control (shaded light gray); mock-infected (shaded dark gray); and uninfected (PLAP) and infected (PLAP+)
fraction of cells exposed to HIV (dotted and solid lines, respectively). (D) Jurkat T cells transiently transfected with HIV-1 LTR-luc alone or in combination
with a Nef expression vector were stimulated by antibodies specific for CD3 and CD28 for 12 h. Induction of LTR activity was assessed by measuring
luciferase activity. Each bar represents at least three transfections and error bars represent standard deviations. These data are representative of three
independent experiments. (E) CD4 expression in infected cells with or without Nef. The histograms are: isotype control (dotted line); mock-infected (light
gray); HIV-Nef+ (thick line); and HIV-Nef (thin line).
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surface expression was reduced by HIV-Nef+-infected cells,
indicating that the HXB2 Nef expressed from the HXB2-
PLAP clone was functional (Fig. 1E). Thus, Nef does not
inhibit CD28 expression or function in infected CD4+ Tcells.
Nef modifies tyrosine phosphorylation in unstimulated
T cells
To determine if Nef could directly influence T cell
signal transduction, cells were infected with HIV-Nef+ or
HIV-Nef, and whole-cell extracts were examined for
overall tyrosine phosphorylation. Several proteins were
phosphorylated in unstimulated HIV-Nef+-infected cells,
compared to mock-infected and HIV-Nef infected cells.
In HIV Nef+ cells, hyper-phosphorylation was usually seen
for proteins of sizes 22 kDa, 75 kDa, and 120 kDa,
whereas tyrosine phosphorylation of a protein at 65 kDa
was reduced (Fig. 2A). Although there were some
variations in the degree of Nef-induced phosphorylation
for the 22-kDa and 75-kDa proteins, the 120-kDa proteinwas always hyper-phosphorylated by approximately two
fold (Fig. 2B). These observed changes of protein tyrosine
phosphorylation are consistent with the hypothesis that Nef
modifies T cell signal transduction.
The ability of Nef to alter signaling following T cell
activation was also examined. Jurkat cells were infected
with HIV-Nef+ or HIV-Nef, stimulated with anti-CD3 and
anti-CD28 antibodies, and assessed for changes in tyrosine
phosphorylation. Upon CD3/CD28 co-stimulation, changes
in protein tyrosine phosphorylation were similar in mock,
HIV-Nef, and HIV-Nef+ infected cells (Fig. 2C). Densito-
metric analysis of phosphorylation at 120 kDa confirmed
the initial observation that Nef increased tyrosine phosphor-
ylation of the 120-kDa protein by two fold in unstimulated
cells but did not contribute to hyper-phosphorylation
following CD3/CD28 co-stimulation (Fig. 2D). Similarly,
CD3/CD28 co-stimulation led to increased phosphorylation
of several other proteins, among them proteins near 75 kDa,
regardless of HIV infection or Nef expression. Overall, Nef
did not enhance post-activation phosphorylation events.
Taken together, these observations indicate that Nef
Fig. 2. Nef alters tyrosine phosphorylation in infected Jurkat T cells. (A) Whole-cell extracts from Jurkat T cells that were mock-infected (mock) or infected
with HIV-Nef+ (Nef+) or HIV-Nef (Nef) were resolved on 9% SDS-PAGE and transferred to PVDF membrane for immunodetection of tyrosine
phosphorylation with a monoclonal anti-phosphotyrosine antibody. The blot was stripped and subsequently reprobed for c-Cbl and Nef expression. The ‘‘+’’
and ‘‘’’ indicate increases and decreases in tyrosine phosphorylation, respectively, in the Nef+ sample. Different exposure times were employed to encompass
the range of phosphorylation changes. (B) Densitometric analysis of the 120-kDa phosphoprotein/c-Cbl ratios in (A), normalized to unstimulated, mock-
infected population. (C) Jurkat T cells infected as those in (A) were either untreated, or treated with 1 Ag/ml anti-CD3, 1 Ag/ml anti-CD28, and 7.5 Ag/ml goat-
anti-mouse antibodies before lysis and immunoblotting. Blots were probed with anti-phosphotyrosine, anti-c-Cbl, and anti-Nef antibodies as in (A). (D) The
signal intensity of the 120-kDa phosphoprotein relative to c-Cbl expression was measured by densitometry. For these experiments, HIV infection was assessed
by staining with anti-PLAP antibody and flow cytometry (data not shown).
P. Yang, A.J. Henderson / Virology 336 (2005) 219–228222primarily enhances tyrosine phosphorylation in the context
of unstimulated T cells.
Nef induces phosphorylation of c-Cbl
C-Cbl is a proto-oncoprotein that regulates T cell
signaling by targeting proteins such as ZAP-70 and Vav
(Fournel et al., 1996; Marengere et al., 1997; Thien and
Langdon, 2001). Its expression in Jurkat T cells was
previously reported (Donovan et al., 1994). The size of c-
Cbl and its critical role in controlling T cell activation made
this protein an attractive candidate for the 120-kDa
phosphoprotein observed in cells infected with HIV-Nef+
(Fig. 2A). Reprobing with anti-c-Cbl antibody confirmedthat c-Cbl co-localized with the 120-kDa phosphoprotein
(Fig. 2). To confirm that c-Cbl phosphorylation was
enhanced by Nef following infection, cell extracts were
immunoprecipitated with anti-c-Cbl antibody and phosphor-
ylation status assessed with anti-pTyr antibody. The identity
of pull-down products was confirmed by reprobing immu-
noblots with anti-c-Cbl antibody. More phosphorylated c-
Cbl was pulled-down from HIV-Nef+-infected cells, com-
pared to c-Cbl immunoprecipitated from cells infected with
HIV-Nef (Fig. 3). Expression of c-Cbl was not altered by
HIV infection or Nef expression, since comparable levels of
c-Cbl protein were present in the whole-cell extracts (Fig. 3;
data not shown). These data are consistent with c-Cbl being
a target of HXB2 Nef in HIV-infected cells.
Fig. 3. c-Cbl is hyper-phosphorylated in HIV-Nef+-infected Jurkat T cells.
C-Cbl protein was immunoprecipitated with polyclonal rabbit anti-c-Cbl
antibody from whole-cell lysates of HIV-Nef+ or HIV-Nef infected cells
and probed with anti-pTyr antibody. Filters were stripped and reprobed with
anti-c-Cbl antibody to assure similar amounts of protein were immunopre-
cipitated. Nef expression was confirmed by immunoblotting whole-cell
extracts from the infected cells.
Fig. 4. Intracellular Nef mediates c-Cbl phosphorylation. (A) Cells infected
with HIV-Nef+ or HIV-Nef were positively selected for PLAP expression
using the Dynal cell separation system. The PLAP expression profiles of
cell populations before and after enrichment are shown. Shaded peaks
represent isotype control; dotted line (which completely overlaps with the
isotype control) and solid line represent PLAP and PLAP+ populations,
respectively. (B) Induction of phosphorylation in Nef+ HIV-infected cells.
Jurkat T cells were infected with HIV-Nef+ and HIV-Nef and separated
into PLAP+ and PLAP populations. Whole-cell extracts were prepared
from equal number of cells, and tyrosine phosphorylation was assessed by
immunoblotting. Blots were stripped and reprobed subsequently for c-Cbl
and Nef expressions. (C) c-Cbl protein was immunoprecipitated from
PLAP+ and PLAP sorted cells and probed with anti-pTyr antibody and
subsequently stripped and reprobed with anti-c-Cbl antibody. Phospho-c-
Cbl relative to total c-Cbl was assessed by densitometry.
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infected T cells
Nef has been shown to influence cell function
endogenously by interacting with signaling molecules
anchored to the inner leaflet of the cytoplasmic mem-
brane, or as an extracellular soluble factor (Fackler and
Baur, 2002; Renkema and Saksela, 2000). To determine
whether changes in phosphorylation patterns are caused
by intracellular or extracellular Nef, PLAP+, and PLAP
fractions were obtained following infection with HIV-
Nef+ and HIV-Nef (Fig. 4A). Both PLAP+ and PLAP
cells would have been exposed to soluble viral proteins,
but cells that are infected (PLAP+) express viral proteins
intracellularly. Whole-cell extracts prepared from PLAP-
sorted cells were examined by immunoblotting using an
anti-phosphotyrosine antibody. Increased tyrosine phos-
phorylation of several proteins, including 120 kDa and 75
kDa proteins, was observed in HIV-infected cells com-
pared to uninfected (PLAP) or HIV-Nef infected cells
(Fig. 4B). Furthermore, enhanced c-Cbl phosphorylation
was only observed in PLAP+, HIV-Nef+ infected cells,
whereas only modest c-Cbl phosphorylation was observed
in the PLAP fraction (Fig. 4C) or cells infected with
HIV-Nef (data not shown). These results indicate that
Nef expression in HIV-infected cells is responsible for
altered phosphorylation patterns in infected unstimulated
T cells.
Lck is required for Nef-mediated enhancement of c-Cbl
tyrosine phosphorylation
Src tyrosine kinases, including Lck in CD4+ T cells,
phosphorylate c-Cbl (Feshchenko et al., 1998; Fournel et al.,
1996). Therefore, Nef, which interacts with Src kinases in
infected cells, could be mediating c-Cbl phosphorylation by
recruiting Src kinases. PP1, a potent inhibitor of Src tyrosinekinases, was used to determine if Src activity was required
for Nef-dependent alteration of c-Cbl phosphorylation (Liu
et al., 1999). As shown in Fig. 5A, hyper-phosphorylation
of c-Cbl in HIV-Nef+-infected cells was inhibited by
treatment with PP1, suggesting that Src kinases are required
for Nef-induced c-Cbl phosphorylation.
To confirm the role of Lck in Nef-induced c-Cbl
phosphorylation, J.CaM1.6 cells, which lack functional
Fig. 5. Lck is required for Nef-induced c-Cbl tyrosine phosphorylation. (A)
Jurkat T cells uninfected, infected with HIV-Nef+, or HIV-Nef were
treated with 20AM PP1 for 30 min at 37 -C. c-Cbl protein was
immunoprecipitated from whole-cell extracts and tyrosine phosphorylation
was assessed by reprobing with anti-pTyr antibody. Blots were stripped and
reprobed for c-Cbl with anti-c-Cbl antibody. Whole-cell extracts were
blotted with anti-Nef anti-serum to confirm expression. (B) Jurkat T cells
and JCAM1.6 cells were infected with HIV-Nef+ or HIV-Nef. Whole cell
extracts were probed with anti-phosphotyrosine antibody. The phosphory-
lated 120-kDa protein is shown. Blots were stripped and reprobed with an
anti-Cbl antibody. Jurkat and J.CaM1.6 cells are equally susceptible to
infection with HIV-Nef+ and HIV-Nef virus as determined by Gag
immunoblot and flow cytometric analysis for PLAP expression (data not
shown).
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or HIV-Nef. In contrast to what was observed in Jurkat T
cells, the 120-kDa protein was not hyper-phosphorylated
upon infection with HIV-Nef+ (Fig. 5B). Taken together,
these data indicate that functional Lck is required for Nef-
dependent phosphorylation of c-Cbl.Discussion
The ability of Nef to interact with a variety of molecules
that participate in signal transduction pathways has led to
speculation that Nef alters T cell activation. Consistent with
this hypothesis, Schrager et al. reported Nef enhances T cell
activation in response to TCR-CD28 signaling (Schrager
and Marsh, 1999; Schrager et al., 2002). Nef has been
shown to physically interact with Vav, Lck, and CD3-~(Cheng et al., 1999; Fackler et al., 1999; Xu et al., 1999),
suggesting that it directly participates in TCR signaling.
Moreover, Nef activates NF-AT through the Ras/MAPK
pathway (Manninen et al., 2000; Schrager and Marsh, 1999;
Schrager et al., 2002). In this study, we have identified c-Cbl
as an additional signaling molecule that is modified by Nef.
With the exception of a protein at 65 kDa which was
hypophosphorylated in Nef-expressing cells, stimulating T
cells through CD3 and CD28 resulted in similar patterns of
tyrosine phosphorylation in mock-, HIV-Nef+ infected, and
HIV-Nef infected cells, suggesting that Nef had little
impact on CD3/CD28-signaling. However, in absence of
CD3/CD28 co-stimulation, cells infected with HIV-Nef+
had a distinct pattern of protein phosphorylation when
compared to mock-infected cells or cells infected with HIV-
Nef. Nef-dependent hyper-phosphorylated proteins
include a subset of proteins such as 120 kDa and 75 kDa,
proteins that were also phosphorylated in response to CD3/
CD28 activation. Although we have not identified these
hyper-phosphorylated proteins, logical candidates include
ZAP-70 and SLP-76. ZAP-70 is regulated by c-Cbl during
T cell activation. Moreover, ZAP-70 is required for Nef-
induced transcription in Nef-expressing CD4+ T cells
(Simmons et al., 2001). On the other hand, SLP-76 is
required for HIV transcription induced by CD43 engage-
ment (Barat and Tremblay, 2002). Taken together, partial
activation of host signal transduction molecules by Nef may
assure a cellular environment that is suitable for proviral
integration and early virus transcription. Nef expression
following HIV infection has been shown to interfere with T
cell functions such as chemotaxis (Janardhan et al., 2004). It
is also suggested that Nef promotes T cell signaling and
provirus integration (Schrager and Marsh, 1999; Wu and
Marsh, 2001). Furthermore, the ability of Nef to induce
limited T cell signaling is consistent with observations that
overexpression of Nef leads to gene expression profiles
similar to those observed in CD3-activated T cells
(Simmons et al., 2001).
We have demonstrated that one target of Nef is c-Cbl.
C-Cbl is a 120-kDa protein that is phosphorylated
following T cell activation (Donovan et al., 1994; Lupher
et al., 1999) and, based on our results, Nef expression upon
HIV infection. C-Cbl regulates T cell signaling by
ubiquitinating tyrosine kinases and downstream signaling
molecules during T cell activation and targeting these
proteins for degradation (Marengere et al., 1997; Miura-
Shimura et al., 2003; Rao et al., 2002; Wang et al., 2001).
In addition to its role as a negative regulator of signal
transduction, c-Cbl functions through SH2 and SH3
domains as an adaptor protein promoting the assembly of
signaling complex (Buday et al., 1996; Fukazawa et al.,
1995). Whether c-Cbl functions as a negative regulator of
T signaling or an adaptor protein is in part determined by
its dynamic tyrosine phosphorylation (Buday et al., 1996).
Induction of c-Cbl phosphorylation by Nef in absence of
stimulation potentially exploits the dual role of c-Cbl as
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Both Nef and c-Cbl target Vav, a GEF that integrates TCR
and CD28 signaling pathways during T cell activation
(Salojin et al., 1999). Nef binding to Vav induces its GEF
activities, leading to recruitment of Rac1/cdc42 and PAKs
that initiate both Sek/Jnk signaling and rearrangement of
the actin cytoskeleton (Fackler et al., 1999). However, Vav
is regulated by c-Cbl through ubiquitination during T cell
activation (Miura-Shimura et al., 2003). Interaction of c-
Cbl and Vav requires phosphorylation of Cbl at Y700
(Thien and Langdon, 2001). Thus, by altering the status of
c-Cbl phosphorylation, HIV potentially controls its ability
to recruit and regulate Vav and/or disrupt the negative
regulation of T cell signaling. It is unclear how Nef
enhances the tyrosine phosphorylation of c-Cbl. C-Cbl is
phosphorylated by Src kinases (Donovan et al., 1994;
Feshchenko et al., 1998; Fournel et al., 1996), which have
been demonstrated to interact with Nef (Baur et al., 1997;
Collette et al., 1996; Saksela et al., 1995), and our results
using the general Src kinase inhibitor PP1 and J.CaM1.6
cells, which lack a functional Lck, indicate that Lck is
required for Nef-dependent c-Cbl tyrosine phosphorylation.
Nef may stabilize a complex that includes c-Cbl, Vav, and
Lck, which then influences T cell signaling and HIV
replication. However, we have not been able to detect a
direct physical interaction between Nef and c-Cbl, suggest-
ing that Nef indirectly modifies c-Cbl function (data not
shown).
The CD28 co-receptor is responsible for sustaining and
amplifying T cell signaling during antigen-dependent
activation (Acuto et al., 2003), however, the ability of Nef
to influence CD28 activity is controversial. Although it has
been reported that CD28 is down-regulated by Nef (Kirchh-
off et al., 2004; Swigut et al., 2001), others have not
detected altered CD28 expression during HIV infection
(Bell et al., 2001). The discrepancies in these observations
may reflect differences in cell systems, ways in which Nef
was over-expressed, or different Nef alleles. We did not see
a decrease in CD28 expression in infected T cells with Nef
derived from HXB2. However, we cannot rule out that Nef
from other primary isolates modulates this co-stimulatory
receptor (Kirchhoff et al., 2004). Furthermore, the ability of
CD28 to provide co-stimulatory signals, as determined by
induced HIV-1 LTR activity, was not compromised by
HXB2 Nef. The Nef allele used for these studies was able to
down-modulate CD4, suggesting that it was functional.
Therefore, our data indicate that HXB2 Nef does not
suppress CD28.
The link between Cbl proteins and HIV pathogenesis
needs to be further delineated. It is observed that expression
of Cbl-b induced by immune activation results in attenu-
ation of HIV-1 replication in HIV-positive patients (Leng et
al., 2002). Nevertheless, this is not sufficient to halt
establishment of persistent and chronic infection. Our study
showed that c-Cbl is modified in a Nef-dependent manner in
HIV infected cells in the absence of activation. Nef may co-opt or modify Cbl proteins to alter or even dysregulate T cell
function. Since HIV transcription and replication is induced
by T cell activation, which is modulated by c-Cbl, altered
biochemical properties of c-Cbl may ultimately contribute to
an intracellular environment that is advantageous for HIV
replication.Materials and methods
Cells and plasmids
Human acute T cell leukemia cell line Jurkat T E6-1,
obtained from ATCC (Manassas, VA), J.CaM1.6, a Lck-
deficient line derived from Jurkat (Straus and Weiss, 1992)
(kind gift from Dr. Avery August, the Pennsylvania State
University), and ACH-2, an HIV-1 latent T cell line (Clouse
et al., 1989), were maintained in RPMI 1640 medium
supplemented with 5% fetal calf serum (FCS), 100 units/ml
penicillin, 100 Ag/ml streptomycin, and 0.2 M l-glutamine.
Human embryonic kidney cells 293T (ATCC, Manassas,
VA) and Chinese hamster ovary (CHO) cells stably
expressing FcRII receptors (CHO-Fc) (Miettinen et al.,
1992) (kind gift of Dr. Avery August, the Pennsylvania State
University) were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% FCS, 100 units/ml
penicillin, 100 Ag/ml streptomycin, and 0.2 M l-glutamine.
The recombinant HIV-1 proviral construct pNL4-3 (Adachi
et al., 1986) and HIV-1 reporter constructs pHXBnPLAP-
IRES-N+ (pHIV-Nef+) and pHXBnPLAP-IRES-N (pHIV-
Nef) encoding infectious molecular clones of HXB2 with
or without functional Nef open reading frame (Chen et al.,
1996), were obtained from the AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID,
NIH. The Nef expression construct pCMV4-NefHA/neor
was a kind gift of Dr. Warner Greene (Gladstone Institute,
UCSF) (Schaeffer et al., 2001). The HIV-1 LTR reporter
construct pLTR-Luc was previously described (Henderson
et al., 1995).
Generation of HIV-1 infectious titers and infections
The generation, collection, and infection with condi-
tioned media containing vesicular stomatitis virus gly-
coprotein (VSV-G) pseudotyped HIV-1 by transient
transfection of 293T using the CaPO4 method was
previously described (Cook et al., 2003). Transfection
efficiency of 293T was determined by co-transfecting 6 Ag
pEGFP-N3 (Clontech, Palo Alto, CA) and monitoring
EGFP expression by fluorescence microscopy. Conditioned
media was filtered with 0.45 Am syringe filter (Whatman,
Clifton, NJ) prior to infection. For HXBnPLAP viruses, the
extent of infection was assessed by flow cytometry using
murine anti-PLAP antibody (Sigma-Aldrich, St. Louis, MO)
and FITC-conjugated anti-mouse antibody (BD Pharmin-
gen, Franklin Lakes, NJ). CD4 and CD28 expression were
P. Yang, A.J. Henderson / Virology 336 (2005) 219–228226assessed by flow cytometry as previously described (Cook
et al., 2003). In some experiments, infected cells were sorted
for PLAP expression using magnetic beads coated with anti-
PLAP antibody, as previously described (Cook et al., 2003).
There was no significant differences in the ability of the
HIV-Nef+ and HIV-Nef viruses to establish infection as
determined by PLAP expression and/or immunoblotting for
Gag (data not shown).
Transfection and luciferase activity assay
1.5  107 Jurkat T cells were washed once in RPMI
with 20 mM HEPES. Washed cells were resuspended in
400 Al RPMI with 20 mM HEPES with 5 Ag LTR-Luc and
10 Ag Nef expression construct pCMV4-NefHA or a start
codon-deficient control vector based on a pCMV backbone
(a kind gift of Dr. Louis Hodgson, University of North
Carolina) and electroporated using a T820 square electro-
poration system (BTX, San Diego, CA) with one pulse for
65 mS at 215 V in a 4-mm cuvette. Transfection efficiency
was determined by co-transfection of pEGFP-N3 and
monitoring by FACS and fluorescence microscopy of
EGFP expressions. Cells were allowed to recover in RPMI
with 5% FCS for 24 h before assaying for luciferase
activity. Separately, CHO-Fc cells were plated in 24-well
plates at 1  105 per well 24 h prior to assay, treated with
12.5 Ag/ml of mitomycin-C in serum-free DMEM for 2 h,
and washed four times with PBS. Transiently transfected
Jurkat T cells were then overlayed at 1  106/well in 500
Al RPMI with 5% FCS. Antibodies were added to the co-
culture at 0.05 Ag/ml anti-CD3 and/or 1 Ag/ml anti-CD28
for cross-linking by CHO-Fc. The Jurkat T-CHO-Fc co-
culture was then incubated at 37 -C for 12 h before lysis
and assaying luciferase activities using a commercial
luciferase assay kit (Promega, Madison WI). Luciferase
units were measured using a TD-20/20 luminometer
(Turner BioSystems, Sunnyvale, CA).
Immunoblots
Jurkat T cells and J.CaM1.6 were either mock-infected
with 293T-conditioned media without infectious virus, or
infected with NL4-3 HIV, HIV-Nef+, or HIV-Nef as
described above. The infected cells were serum-starved 12
h with or without stimulation. Where stimulation was
performed, cells were treated with 1.0 Ag/ml mouse anti-
human CD3 and 1.0 Ag/ml anti-human CD28, antibodies (BD
Pharmingen, Franklin Lakes, NJ) and cross-linked with 7.5
Ag/ml goat anti-mouse antibody (Sigma-Aldrich, St. Louis,
MO) on ice (Cook et al., 2003). Separately, ACH-2 cells were
stimulated with 10 ng/ml of PMA (Sigma-Aldrich) for 24 h
prior to lysis. Src kinases were inhibited by treating cells with
20 AM of PP1 at 37 -C for 30 min. Whole cell extracts were
prepared by treating cells with lysis buffer (10 mM Tris–HCl
(pH 7.4), 150 mM NaCl, 1.0 mM EDTA (pH 8.0), 2.0 mM
sodium vanadate, 10 mM sodium fluoride, 10 mM sodiumpyrophosphate, 1% Nonidet P-40, 1.0 mM phenylmethylsu-
fonyl fluoride, 1.0 mM pepstatin) at 4 -C for 30 min for
protein extracts. Samples were mixed with 2 SDS loading
buffer containing dithiothreitol and heated at 100-C for 5 min
before resolving by SDS-PAGE with 9% polyacrylamide
unless otherwise specified. Proteins were transferred to
PVDF membrane (Millipore, Billerica, MA), blocked with
2% BSA (for the anti-pTyr antibody) or 5% non-fat dry milk
(for all other antibodies) in PBS with 0.02% v/v Tween-20,
and detected with primary antibodies against phosphotyr-
osine (P-Tyr-100, Cell Signaling Technology, Beverly, MA),
and human c-Cbl (Santa Cruz Biotechnology, Santa Cruz,
CA). HIV infection was assessed by reprobing with anti-HIV-
1 Gag antibody (data not shown)(Sigma-Aldrich, St. Louis,
MO) or HIV-1 Nef antiserum (Shugars et al., 1993). Blots
were developed using an ECL-plus kit (Amersham Bio-
sciences, Piscataway, NJ). In some cases, densitometric
analysis of band signal intensities was performed with a
Personal Densitometer SI coupled with ImageQuant analysis
tool (Amersham Biosciences, Piscataway, NJ). For reprob-
ing, blots were stripped with 100 mM 2-mercaptoethanol,
62.5 mM Tris–HCl (pH 6.7), 2% w/v SDS for 30 min at
65 -C with intermittent shaking, and reblocked for 1 h prior
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